52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or Spine
Clinical trial NCT00145301 · COMPLETED
Trial details
- NCT number
- NCT00145301
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2005-11-01
- Enrollment
- 3036
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.